Contrave is a U.S. prescription combination of naltrexone hydrochloride and bupropion hydrochloride in extended-release tablets. Its labeling covers long-term weight management for certain adults with obesity, or overweight accompanied by a weight-related condition, along with dietary and physical-activity measures. Obtaining Contrave requires clinical review because its two ingredients create important interaction, seizure, blood-pressure and mood-related considerations. A pharmacy listing should describe the approved combination product, not simply advertise two unrelated ingredients.
Before arranging a Contrave prescription, confirm the exact branded extended-release formulation, identify the licensed pharmacy responsible for dispensing it, and ask how coverage and the full cost will be verified. Be wary of offers for an unspecified 'generic combination' that do not identify an FDA-approved finished drug product. Purchasing questions differ from the clinical comparison in orlistat versus Contrave. Separate tablets of naltrexone and bupropion are not automatically equivalent to the approved fixed-dose, extended-release Contrave product and should not be presented as a retail substitute.
OrliLab is an independent educational site that may earn affiliate revenue from referrals; it does not dispense medication, prescribe treatment or maintain live pharmacy prices. Contrave carries a boxed warning on suicidal thoughts and behaviors and has significant contraindications. An offer promising easy approval without review of opioid use, seizure risks and other medicines should not be treated as a legitimate shortcut to treatment.
The U.S. Contrave tablet contains 8 mg naltrexone hydrochloride and 90 mg bupropion hydrochloride in an extended-release formulation. A medicine advertised as 'naltrexone plus bupropion' could instead refer to separate drugs or an unverified compounded preparation. The buyer should verify the exact prescribed brand, dosage form, strength and manufacturer identity with the dispensing pharmacy.
Approved treatment and instructions are tied to the specific formulation. An online seller cannot establish equivalence merely by combining ingredient names or total milligrams. A clinician decides whether the approved product is appropriate; a pharmacist checks that the prescription and supplied package match. Do not reconstruct its regimen from individually sold tablets.
A licensed clinician evaluates the patient's weight-management goals, relevant medical conditions, blood pressure, seizure history, mental-health history, current medications and any use of opioid medicines before considering Contrave. The label describes both contraindications and monitoring obligations, so the consultation should be more than a brief marketing questionnaire. Paying for a visit does not guarantee prescribing.
The prescription is then sent to a licensed pharmacy, where product identity, dosage instructions and lawful dispensing are checked. Verify whether an online care platform performs the clinical visit itself or connects the patient with a separate medical professional and pharmacy. A delivery promise is not evidence that medical approval will occur.
Before submitting a prescription or payment information, identify the business that will actually dispense the medication, its U.S. licensing, pharmacy contact details and pharmacist availability. Sites that ignore prescription requirements or conceal their shipping origin may be selling an unverified medicine rather than Contrave as labeled in the United States.
Ask whether the pharmacy expects to fill branded Contrave, what happens if the item is unavailable, and what product appears on the final dispensing label. See online medication safety for broader counterfeit and misleading-seller signals, while using the fixed-dose formulation checklist on this page for product-specific confirmation.
The amount paid can depend on pharmacy, quantity, insurer formulary rules, benefit exclusions, deductible status and any manufacturer or third-party savings program. Counseling visits or subscription services may add charges unrelated to the drug. A discounted headline figure is not meaningful until eligibility criteria, the actual prescribed product and the full checkout total are known.
Request a current pharmacy quote for Contrave extended-release tablets and a separate explanation of any appointment or fulfillment charge. Ask whether coverage depends on prior authorization and whether a promotion applies to the patient's coverage type. OrliLab does not publish undated dollar offers or claim that a particular savings program will remain available.
| Cost component | Check with | Typical uncertainty |
|---|---|---|
| Medication and quantity | Dispensing pharmacy | Final brand price |
| Insurance eligibility | Plan and pharmacy | Formulary exclusions or authorization |
| Savings terms | Program administrator | Patient and coverage restrictions |
| Medical visit | Care provider | Fees even without prescription |
| Delivery or refill | Dispensing pharmacy | Shipping and renewal terms |
Naltrexone is an opioid antagonist. Contrave has important contraindications involving chronic opioid use, opioid agonists or partial agonists, and acute opioid withdrawal. Attempting to start it while using opioids can interfere with analgesia or precipitate withdrawal. This is a safety issue the prescribing clinician must review, not a condition to disclose only after a pharmacy order is shipped.
Tell the prescriber about opioid pain medicines, certain opioid-containing cough medicines, and medicines used to treat opioid use disorder, including methadone or buprenorphine when relevant. Surgery or acute pain treatment may require careful coordination. Patients should not stop or adjust opioid treatment themselves merely to meet the requirements of a medicine-shopping website.
Bupropion creates dose-related seizure concerns. Contrave is contraindicated in people with seizure disorders and certain other situations, including uncontrolled hypertension, eating disorders such as bulimia or anorexia nervosa, and concurrent use of other bupropion-containing products. Abrupt withdrawal from some sedatives or alcohol can also affect eligibility. These are not details that can safely be inferred from a product category page.
Clinical evaluation may require discussion of blood pressure and pulse, psychiatric medicines, antidepressants and additional seizure-threshold-lowering drugs. Prescription instructions also address alcohol, high-fat meals and other factors that can affect safety. Follow the exact labeling and clinician's instructions; the pharmacy should not substitute a more convenient combination based on a commercial quote.
Contrave carries a boxed warning about suicidal thoughts and behaviors associated with antidepressant medicines, including the increased risk described for children, adolescents and young adults taking antidepressants; Contrave itself is not approved for pediatric use. New or worsening mood symptoms, agitation, unusual behavioral changes or suicidal thoughts require prompt medical attention. Contrave is not approved as an antidepressant treatment, and monitoring for emerging or worsening psychiatric symptoms remains important during treatment.
The prescriber should explain mental-health monitoring and what to do if concerning symptoms arise. A retail coupon or telehealth checkout cannot replace that discussion. The prescription pathway is legitimate only when it includes clinically appropriate assessment and an identifiable dispensing pharmacy.
As of the latest reviewed U.S. approval information, there is no FDA-approved generic of Contrave's fixed-dose 8 mg/90 mg extended-release tablet. A claim such as 'generic Contrave' may instead describe separate generic components or an unidentified preparation; verify any purported new approval rather than relying on an advertisement. Do not assume an FDA-approved interchangeable generic Contrave exists simply because naltrexone and bupropion are each marketed individually. Equivalence depends on the actual fixed-dose product, extended-release characteristics and FDA regulatory status.
Ask the pharmacist to identify the approved application and exact dispensed product if a seller proposes an alternative. Buying individual tablets and combining them without clinical direction is not a safe, automatic replacement. This distinction is central to this brand-specific page and should not be obscured by a purported bargain.
Contrave works through a different ingredient combination from orlistat's local intestinal lipase inhibition or GLP-1 medicines such as Foundayo. Tablet form alone is not a clinically meaningful measure of interchangeability. Distinct labels specify different contraindications, monitoring and administration requirements, and clinical outcomes from separate trials should not be compared as if a direct head-to-head study occurred.
To understand alternative oral treatment mechanisms and access differences, review oral GLP-1 comparisons or the dedicated Foundayo access guide. A clinician should determine whether any switch or alternative is appropriate.
A credible pharmacy confirms a valid prescription, the exact branded extended-release product, quantity, order status and where a patient can obtain counseling. Shipping or pickup timelines start from actual pharmacy processing, not the moment a user completes a medical questionnaire. Product listing visibility does not prove that a pharmacy has Contrave in stock.
When the medication arrives, compare the pharmacy label, prescribed brand, quantity, directions and packaging with what the clinician ordered. Keep the pharmacist's contact details for adverse-effect concerns, missed doses and future refills. Do not open or alter extended-release tablets outside the instructions supplied for the product.
OrliLab explains the regulated buying process and the particular risk of confusing Contrave with separate ingredients. Our information cannot determine medical eligibility, guarantee prescription approval or quote today's price at a named pharmacy. Affiliate referrals, when present, are not evidence that a provider has examined a patient's history or can dispense a specific medicine.
Use the approved label, licensed clinician and dispensing pharmacist for individual questions. A complete purchase decision accounts for interactions, contraindications, coverage and product identity rather than relying on the cheapest advertisement or the fact that several medicines are supplied as oral tablets.
A licensed U.S. pharmacy may dispense Contrave after verifying a valid prescription. Confirm the pharmacy's license, the actual dispensing business, the prescribed extended-release product and stock before paying for an order or delivery service.
It contains naltrexone hydrochloride and bupropion hydrochloride in a fixed-dose extended-release tablet.
Yes. Its U.S. label covers specified adults with obesity or overweight and a weight-related comorbidity, together with dietary and physical-activity measures.
Do not assume equivalence. Separate products are not an automatic substitute for the approved fixed-dose extended-release formulation.
No. Separately available generic naltrexone and bupropion do not establish an FDA-approved generic of Contrave's fixed-dose extended-release tablet. Ask a licensed pharmacist to verify the exact product and any claimed new approval.
Naltrexone blocks opioid receptors, so chronic opioid treatment or acute opioid withdrawal can make Contrave inappropriate and may create serious risks. The clinician needs a complete list of pain medicines and opioid-use-disorder treatments before prescribing.
Yes. Its boxed warning concerns suicidal thoughts and behaviors associated with antidepressants, reflecting its bupropion component. Prescribers should review mood and behavioral changes and explain when urgent medical help is needed.
Contrave is contraindicated in patients with seizure disorders; a clinician must review this and other safety exclusions.
No. Appropriate prescribing requires clinical judgment and may be declined after evaluation.
No. Confirm final cost and inventory directly with the licensed dispensing pharmacy.